Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
FDA Oncology
Oct 30, 2023, 13:42 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
Starting from August 26, which is Women’s Equality Day in the United States—celebrating the 1920…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Oct 15, 2023, 18:52 |
Blog
Ricardo Garcia: Dovitinib has received Orphan Drug Designation (ODD) from the FDA for osteosarcoma.
Ricardo Garcia, CEO and founder of Oncoheroes Biosciences, posted on his LinkedIn page: "Here we…
Oct 14, 2023, 17:49 |
Drugs
Chris Boshoff: the U.S. FDA approved our targeted combination therapy for the treatment of adult patients with BRAF V600E-mutant metastatic non-small cell lung cancer (NSCLC).
Oct 13, 2023, 17:37 |
Blog
Thor Halfdanarson: Dear friends, sincerest thanks for the trust and thanks to Pamela Kunz for model leadership.
Thor Halfdanarson, Professor of Oncology at Mayo Clinic, shared a post by Julie Hallet on…
Oct 9, 2023, 18:53 |
Career
Daniel E. Spratt: It is a huge honor to be the 1st radonc as a full standing member on the FDAs ODAC (I am at least told).
Daniel E. Spratt, Chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical…
Oct 8, 2023, 18:03 |
Insight
Bishal Gyawali: Kudos to the FDA for being proactive and swift in making withdrawal recommendations in recent years.
Bishal Gyawali, Associate Professor at Queen's University, shared on X/Twitter: "When a drug that previously…
Oct 7, 2023, 18:27 |
Opinion
Bishal Gyawali: This offers a good lesson on why oncology KOLs are not always the best person to interpret the results of a trial.
Quoting Bishal Gyawali, Associate Professor at Queen’s University, on LinkedIn: “This is from FDA’s ODAC…
Oct 6, 2023, 16:09 |
Blog
Giselle Sholler: The FDA-ODAC said YES to DFMO!!
Quoting Giselle Sholler, Division Chief Pediatric Hematology, Oncology, BMT at Penn State Health Children's Hospital,…
Oct 2, 2023, 18:25 |
Blog
W. Michael Korn: The FDA just granted marketing authorization for the Invitae Common Hereditary Cancers Panel.
W. Michael Korn, Chief Medical Officer for Oncology at Invitae, shared on LinkedIn: “The FDA…
18
19
20
21
22
All:
562
Posts:
191 - 200
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube